FEED NASDAQ
ENvue Medical, Inc.
1W: -4.2%
1M: -37.1%
3M: -73.3%
YTD: -85.4%
$0.34
-0.01 (-4.19%)
Weekly Expected Move ±14.7%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.4M
52W Range0.335-5.98
Volume106,949
Avg Volume930,679
Beta1.56
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODoron Robert Besser
Employees14
SectorHealthcare
IndustryMedical - Specialties
IPO Date2025-12-12
Websiteenvuemed.com
969 Pruitt Ave
Tyler, TX 77569
US
Tyler, TX 77569
US
1 914 233 3004
About ENvue Medical, Inc.
NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span across several global markets, such as the United States, Europe, Australia, India, and Israel, in addition to other territories. This enterprise was founded by Harold Jacob and Jona Zumeris in September 2003, and its main corporate office is situated in Tyler, Texas.
Latest News
ENvue Medical Unveils Its First Robotic-Assisted, Artificial Intelligence, Feeding Tube Automation Tool
12 Health Care Stocks Moving In Wednesday's Intraday Session
Why 8x8 Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue™ Navigation Platform Becomes Standard of Care
ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Glibert Christian Mi | J-Other | 0 | — | 2026-04-15 |
| BANK OF AMERICA CORP | S-Sale | 100 | $3.05 | 2026-02-02 |
| BANK OF AMERICA CORP | S-Sale | 10 | $3.05 | 2026-02-02 |
| BANK OF AMERICA CORP | S-Sale | 4 | $3.05 | 2026-02-02 |
| BANK OF AMERICA CORP | S-Sale | 4 | $3.05 | 2026-02-02 |